Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall St tumbles as hot CPI boosts rate-hike bets; banks, AI stocks weigh
- Oil prices steady after gains on Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts NRIX Hot Sheet
Join SI Premium – FREE
Nurix Therapeutics, Inc. (NASDAQ: NRIX) reported Q3 EPS of $4.73, versus ($1.03) reported last year. Revenue for the quarter came in at $673.1 million, versus $7.9 million reported last year.
For earnings history and earnings-related data on Nurix Therapeutics, Inc. (NRIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix (NRIX) PT Lowered to $33 at Truist Securities
- Trump's Son-in-law Is Subject Of New Lawsuit By Watchdog Group - Bloomberg
- CBL Properties (CBL) Declares $0.625 Quarterly Dividend; 5.3% Yield
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
